http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db99f75cf648ff2ada829d42f2340c4f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Fazio |
| name | Sergio Fazio |
| given-name | Sergio |
| organization-name | From the Department of Medicine (U.K.A.S., T.L.E., E.J., M.W., S.F., E.K.K., W.J.B., L.L.), Department of Pathology, Microbiology, and Immunology (U.K.A.S., S.F.), and Department of Radiology and Radiological Sciences (U.K.A.S.), Vanderbilt University Medical Center, Nashville, TN; International Epidemiology Institute, Rockville, MD (H.M., W.J.B.); School of Osteopathic Medicine, University of Medicine and Dentistry, Newark, NJ (M.G.W.); and Department of Medicine, University of Cape Town, Cape Town... Vanderbilt University Medical Center, Atheroscolosis Research Unit, Division of Cardiovascular Medicine, Nashville, Tennessee 37232-6300 Oregon Health & Science University Portland From the Department of Medicine (V.R.B., L.D., S.F., M.F.L.), Pediatrics (J.R., S.K.D.), Molecular Physiology & Biophysics (J.D.M.), Nephrology (M.D.B.), Pathology (S.F.), and Pharmacology (M.F.L.) of Vanderbilt University Medical Center, Nashville, Tenn. From the Center for Preventive Cardiology of the Knight Cardiovascular Institute, Department of Medicine, Oregon Health & Science University, Portland. From the Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Departments of Medicine (H.T., J.L.B., P.G.Y., L.D., M.F.L., S.F.), Pharmacology (M.F.L.), and Pathology, Microbiology, and Immunology (S.F.), Vanderbilt University Medical Center, Nashville, TN; and Department of Cell Biology and Anatomy, School of Medicine, University of South Carolina, Columbia (D.F.). Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR (P.A.M., H.T., K.H., I.G., S.F.). From the Departments of Medicine (J.B.B., V.R.B., S.F., M.F.L.), Pathology (S.F.), and Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn, and the Division of Biological Sciences and Department of Nutrition (K.M., L.M., G.S.H.), Harvard School of Public Health, Boston, Mass. Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon 97239 Regeneron Pharmaceuticals Inc., Tarrytown, NY 10591, USA From the Section of Cardiovascular Disease Prevention, Division of Cardiovascular Medicine, Department of Medicine (H.T., I.G., M.F.L., S.F.), and Departments of Pharmacology (M.F.L.) and Pathology, Immunology and Microbiology (S.F.), Vanderbilt University Medical Center, Nashville, TN. Oregon Health and Science University Portland Oregon United States Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland (P.A.M., H.T., K.T.H., I.G., S.F.). Vanderbilt University Medical Center, Nashville, Tenn From the Division of Cardiovascular Medicine, Section of Cardiovascular Disease Prevention, Vanderbilt University Medical Center, Nashville, TN. From the Departments of Medicine (V.R.B., L.A.G., K.J.C., S.F., M.F.L.), Pathology (S.F.), and Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn; and Department of Molecular Biology and Medicine (H.S., T.K.), University of Tokyo, Tokyo, Japan. From the Departments of Pediatrics and Medicine and Pathology, Vanderbilt University School of Medicine, Nashville, Tenn. Oregon Health and Science University Portland Oregon From the Departments of Medicine (V.R.B., M.Y., L.D., Y.Z., J.M.M., M.F.L.) and Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, TN; Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey (E.E.); Department of Medicine, Oregon Health & Science University, Portland, OR (S.F.); and Department of Genetics & Complex Diseases & Sabri Ulker Center, Harvard School of Public Health, Boston, MA (G.S.H.). Center for Preventive Cardiology of the Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon; and From the Department of Pharmacology, Dalhousie University, Halifax, NS, and Saint John, NB, Canada (S.R.); Department of Medicine, Section of Cardiovascular Disease Prevention, Vanderbilt University, Nashville, TN (H.T., M.F.L., J.H., I.G., S.F.); Oregon Health and Science University, Portland (H.T., I.G.); and Department of Biostatistics, Faculty of Medicine, University of Toronto and Cancer Care Ontario, Toronto, ON, Canada (P.E.B.). From the Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn. Cardiovascular Division, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. From the Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR. Atherosclerosis Research Unit, Departments of Medicine and Pharmacology, Vanderbilt University Medical Center, Nashville, TN; Knight Cardiovascular Institute, Center for Preventive Cardiology, Oregon Health and Science University, Portland, OR From the Department of Medicine, Division of Cardiovascular Medicine (A.S.M., S.F., M.F.L.), the Department of Pathology (S.F.), and the Department of Pharmacology (M.F.L.), Vanderbilt University, Nashville, Tenn. Center of Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon Knight Cardiovascular Institute Center for Preventive Cardiology Oregon Health & Science University Portland OR Oregon Health & Science University, Knight Cardiovascular Institute Center for Preventive Cardiology, Portland, USA From the Department of Pathology (S.F., D.E.D.), Department of Medicine, Division of Cardiovascular Medicine (S.F., M.F.L.), and Department of Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn. Regeneron Pharmaceuticals, Inc. Tarrytown New York USA Atherosclerosis Research Unit, Division of Cardiology, Department of Medicine, Department of Molecular Physiology and Biophysics, Department of Pharmacology, and Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee 37232-6300 From the Departments of Medicine (A.S.M., H.I., Y.R.S., A.M.B., L.L., K.J.C., M.F.L., S.F.), Pharmacology (M.F.L.), and Pathology (D.E.D., S.F.), Vanderbilt University School of Medicine, Nashville, Tenn. Knight Cardiovascular Institute, Center for Preventive Cardiology, Oregon Health & Science University Portland Oregon USA From the Department of Medicine, Knight Cardiovascular Institute, Oregon Health & Science University. From the Departments of Medicine (V.R.B., R.P.R., D.F., L.D., Y.Z., H.T., S.F., M.F.L.), Pathology (S.F.), and Pharmacology (M.F.L.) of Vanderbilt University Medical Center, Nashville, TN; Department of Molecular Biology and Genetics (E.E.), Bilkent University, Ankara, Turkey; Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA (C.Z.G., G.S.H.). From the Department of Genetics, Geisel School of Medicine, Dartmouth College, Hanover, NH (J.B., S.M.W.); Departments of Medicine, Physiology, and Pharmacology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR (I.M.P., S.F.); Department of Epidemiology and Biostatistics, Institute for Computational Biology, Case Western Reserve University, Cleveland, OH (W.S.B.); Department of Internal Medicine, Yale School of Medicine, New Haven, CT (Y.K.); Department of... From the Departments of Medicine (V.R.B., P.G.Y., S.V.R., S.F., M.F.L.), Pharmacology (M.F.L.), Pathology (S.F.), Nephrology (V.K., M.D.B.), and Molecular Physiology & Biophysics (M.A.M.), Vanderbilt University Medical Center, Nashville, Tenn. From the Department of Medicine, Center for Preventive Cardiology, Knight Cardiovascular Institute, Portland, OR (H.T., D.C., D.P., M.D.S., I.G., P.B.D., S.F.); School of Public Health, Oregon Health and Science University, Portland (J.M.); Sulpizio Cardiovascular Center, Vascular Medicine Program, University of California at San Diego, La Jolla (C.Y., S.T.); Inra UMR1280, Université de Nantes, CHU Hôtel-Dieu, Nantes, France (M.C., G.L.); Inserm UMR 1188, Sainte-Clotilde, France (G.L.); Université... From the Department of Pathology (D.E.D., W.G.J., L.L.S., S.F.), the Department of Medicine (Y.R.S., W.Z., M.F.L., S.F.), Division of Cardiovascular Medicine, the Department of Cancer Biology (W.G.J.), and the Department of Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn. Oregon Health & Science University, Knight Cardiovascular Institute, Center for Preventive Cardiology Department of Medicine Knight Cardiovascular Institute, Center for Preventive Cardiology, Oregon Health and Science University Oregon Portland USA From the Division of Cardiovascular Medicine (L.Z., R.C., L.D., Y.Z., A.S.M., M.F.L.), Division of Diabetes, Endocrinology, and Metabolism (L.Z., J.M.S.), Division of Rheumatology, Department of Medicine (M.O.), Vanderbilt University Medical Center, Nashville, TN; Tennessee Valley Healthcare System, Nashville (L.Z., J.M.S.); and Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland (I.G., H.T., S.F.). From the Division of Cardiovascular Medicine, Section of Cardiovascular Disease Prevention (I.M.P., S.F.) and Center for Human Genetics Research (I.M.P., A.R., N.S.-B., N.D.W., W.S.B., J.L.H., S.M.W.), Vanderbilt University Medical Center, Nashville, TN; Department of Biological Sciences, Vanderbilt University, Nashville, TN (A.R.); Department of Anthropology, University of Minnesota, MN (A.D.); Centro di Ricerca, Ospedale San Pietro FBF, Rome, Italy (A.T., G.N., G.S.); Fondazione Bioparco di Roma,... Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland (S.F.). Oregon Health & Science University, Knight Cardiovascular Institute, Center for Preventive Cardiology, USA Department of Medicine Vanderbilt University Medical Center (VUMC) Nashville TN; Department of Pathology, Microbiology and Immunology VUMC Nashville TN From the Section of Cardiovascular Disease Prevention, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN. Oregon Health & Science University, Portland, OR, USA From the Department of Pathology, Microbiology, and Immunology (A.K.S., B.L., S.F., J.B.A., P.P.Y.) and Departments of Veterans Affairs Medical Center (J.B.A., P.P.Y.), Pharmacology (M.F.L.), and Medicine (Y.Z., V.R.B., S.F., M.F.L., P.P.Y.), Vanderbilt University Medical Center, Nashville, TN; Department of Neurodegenerative Diseases, Institute of Neurology, University College London, Queen Square, London, United Kingdom (P.J.); Department of Pathology and Laboratory Medicine, Nationwide Children’s... From the Department of Biochemistry and Molecular Biology (J.L., D.P.T., M.S.S.), East Tennessee State University, Johnson City; and the Departments of Medicine (Y.R.S., M.F.L., S.F.), Pharmacology (M.F.L.), and Pathology (S.F.), Vanderbilt University Medical Center, Nashville, Tenn. From the Sahlgrenska Center for Cardiovascular and Metabolic Research/Wallenberg Laboratory, Department of Molecular and Clinical Medicine (M.G., M.L., K.S., J.P., V.F., P.J., S.-O.O., J.B.), Göteborg University, Sweden; Division of Cardiovascular Medicine (S.F., M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn; Department of Medicine (C.F.S.), Washington University, St Louis, Mo; and Department of Medical Biosciences (G.O.), Umeå University, Sweden. Oregon Health & Science University, Portland, Oregon (M.D.S., J.M., H.T., S.F.) Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee From the Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Departments of Medicine (W.Z., P.G.Y., Y.R.S., V.B., Y.Z., S.F., M.F.L.), Pharmacology (M.F.L.), and Pathology (S.F.), Vanderbilt University Medical Center, Nashville, Tenn. Regeneron Pharmaceuticals Inc. , Tarrytown, NY , USA Department of Medicine, Cardiovascular Division, Vanderbilt University Medical Center, Nashville, Tennessee. Knight Cardiovascular Institute, Center for Preventive Cardiology, Oregon Health and Science University, Portland (S.F.). Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN; and From Atherosclerosis Research Unit (P.G.Y., J.B., L.D., D.F., C.D.O., Y.Z., M.F.L., S.F.), Division of Cardiology, Department of Medicine, Department of Pathology (C.D.O., S.F.), and Department of Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn. From the Division of Cardiovascular Medicine, Department of Medicine (S.F., M.F.L.), and the Departments of Pathology (S.F.) and Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn. 5Cardiovascular Division, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR; 8Department of Medicine, Stanford University, Stanford, CA Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center, Nashville, TN, USA; Department of Pathology, Vanderbilt University Medical Center, Nashville, TN, USA Department of Medicine, Center for Preventive Cardiology of the Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR, USA Divisions of *Cardiovascular Medicine and; Pathology, Vanderbilt University School of Medicine, Nashville, TN 37232-6300; From the Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University, School of Medicine, Nashville, Tenn. Departments of Medicine, Pathology, Vanderbilt University Medical Center, Nashville, TN USA. [email protected] Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. From the Center for Preventive Cardiology, Knight Cardiovascular Institute (T.M.K., B.A.W., J.M., J.R.M., P.B.D., J.Q.P., S.F., M.D.S.), Oregon Health & Science University, Portland. Section of Prevention of Cardiovascular Disease; Vanderbilt University Medical Center; Nashville Tennessee Departments of Medicine, Pathology, and Pharmacology, Vanderbilt University, Nashville, TN 37232 2Department of Medicine, Cardiovascular Division, Vanderbilt University Medical Center, Nashville, Tennessee; and From the Departments of Pathology (A.H.H., S.F.), Medicine (M.F.L., S.J.B., V.R.B., L.A.G., S.F.), Pharmacology (M.F.L), Cell Biology (S.J.B), and Veterans Affairs (S.J.B), Vanderbilt University Medical Center, Nashville, Tenn. Center for Preventive Cardiology, Oregon Health & Science University; 3181 Sam Jackson Park Road, Portland, OR 97239, USA Oregon Health & Science University, Portland, Oregon Department of Medicine, Knight Cardiovascular Institute, Oregon Health & Sciences University, Portland, Oregon Vanderbilt University, Nashville TN From the Research Department and Geriatric Research, Education, and Clinical Center, VA Tennessee Valley Healthcare System, Nashville (J.B.B.); Department of Genetics and Complex Diseases, Harvard School of Public Health, Boston, Mass (K.M., L.M., G.S.H.); and Departments of Medicine (J.B.B., V.R.B., S.F., M.F.L.), Pathology (S.F.), and Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn. Dr Maeda is currently with the Medical Center for Translational Research, Osaka... From the Knight Cardiovascular Institute, Center for Preventive Cardiology, Oregon Health & Science University, Portland, OR. From the Departments of Medicine (all authors), Pediatrics (H.Y.), Pathology (S.F.), and Pharmacology (M.F.L.), Vanderbilt University School of Medicine, Nashville, Tenn. Departments of Medicine, Physiology and Pharmacology, Knight Cardiovascular Institute, Center of Preventive Cardiology, Oregon Health & Science University , Portland, OR, USA From the Atherosclerosis Research Unit (P.G.Y., H.Y., M.F.L., S.F.), Division of Cardiovascular Medicine, Departments of Medicine, Pharmacology (S.F.), and Pathology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn. Department of Medicine Vanderbilt University Medical Center (VUMC) Nashville Tennessee; Department of Pathology Microbiology and Immunology VUMC Nashville Tennessee The Center for Preventive Cardiology at the Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR From the Gladstone Institute of Cardiovascular Disease (S.F.), Cardiovascular Research Institute, University of California, San Francisco, and the Lipid and Lipoprotein Research Group and Department of Biochemistry (Z.Y.), University of Alberta, Edmonton, Canada. Vanderbilt University Medical Center, Section of Cardiovascular Disease Prevention, Nashville, TN From the Atherosclerosis Research Unit, Department of Medicine, Division of Cardiovascular Medicine (Y.R.S., D.E.D., A.S.M., M.F.L., S.F.), Department of Molecular Biology and Molecular Biophisics (A.H.H.), Vanderbilt Microarray Shared Resource (B.B.), Department of Pharmacology (M.F.L.), and Department of Pathology (S.F.), Vanderbilt University Medical Center, Nashville, Tenn. From the Departments of Pediatrics (S.Y., R.K., A.B.F., I.I., V.K.), Medicine (P.G.Y., A.B.F., M.F.L., S.F.), Pathology (Y.Z., L.-J.M., A.B.F., S.F.), and Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, TN. From the Departments of Medicine, Divisions of Cardiovascular Medicine (M.F.L., A.S.M., S.F.), Pharmacology (M.F.L.), and Pathology (S.F.), Vanderbilt University School of Medicine, Nashville, Tenn. From the Departments of Medicine/Division of Cardiovascular Medicine (A.S.M., J.L.M., Y.R.S., S.F., M.F.L.), Microbiology and Immunology (M.T.W., A.K.S., S.J., L.V.K.), Pathology (S.F.), and Pharmacology (M.F.L.), Vanderbilt University School of Medicine, Nashville, Tenn. Oregon Health & Science University, Portland, OR 97239, USA From the Division of Cardiovascular Medicine, Atherosclerosis Research Unit, Vanderbilt University Medical Center, Nashville, TN. Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon (T.M.K., S.F., M.D.S.) From the Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Departments of Medicine (H.Y., W.Z., P.G.Y., Y.Z., S.F., M.F.L.), Hematology (M.J.K), Pharmacology (M.F.L.), and Pathology (S.F.), Vanderbilt University Medical Center, Nashville, Tenn. From the Department of Medicine (V.R.B., H.I., L.D., P.G.Y., D.E.D., S.F., M.F.L.), Pathology (S.F.), and Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn; Division of Endocrinology and Metabolism (W.J.K.), University of Texas, Dallas, Tex; and Washington University (C.F.S.), St. Louis, Mo. Departments of 1Pathology,; Medicine, From the Atherosclerosis Research Unit, Department of Medicine (V.R.B., L.D., Y.Z., J.M.M., M.R.F.L.) and Pharmacology (M.R.F.L.), Vanderbilt University Medical Center, Nashville, TN; Center for Cancer Research, National Cancer Institute, Frederick, MD (P.C.L.); and Department of Medicine, Center of Preventive Cardiology, Oregon Health & Science University, Portland, OR (S.F.). Knight Cardiovascular Institute, Center for Preventive Cardiology Oregon Health and Science University Portland OR USA Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, Oregon From the Department of Medicine, Division of Cardiovascular Medicine (S.F., M.F.L.), the Department of Pathology (S.F.), and the Department of Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn. Department of Medicine, Oregon Health and Science University, Portland, Oregon. From the Atherosclerosis Research Unit (C.D.O., P.G.Y., A.S.M., M.F.L., S.F.), Division of Cardiology, Department of Medicine; and Departments of Pathology (C.D.O., S.F.) and Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn. From the Department of Medicine, Division of Cardiovascular Medicine, Atherosclerosis Research Unit (Y.R.S., J.L.B., Y.Z., M.F.L., S.F.), the Department of Pharmacology (M.F.L.), and the Department of Pathology (S.F.), Vanderbilt University Medical Center, Nashville, Tenn. From The Knight Cardiovascular Institute, Oregon Health and Science University, Portland. From the Atherosclerosis Research Unit, Division of Cardiology, Department of Medicine (Y.D., P.G.Y., D.F., J.L.B., Y.Z., L.D., M.F.L., S.F.), Department of Pharmacology (M.F.L.), and Department of Pathology (S.F.), Vanderbilt University Medical Center, Nashville TN; and Laboratory Animal, Jilin University, Changchun, China Center (Y.D., J.Z.). From the Department of Medicine (M.F.L., S.F.), Pharmacology (M.F.L.), and Pathology (S.F.), Vanderbilt University Medical Center, Nashville, Tennessee. Division of Endocrinology, Department of Medicine, Vanderbilt University School of Medicine, Medical Center North, Nashville, TN 37232-2250, USA. Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232 From the Center for Preventive Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland. PORTLAND, OREGON. Department of Medicine, Atherosclerosis Research Unit, Vanderbilt University School of Medicine, Nashville, TN, USA |
Incoming Links
Showing number of triples: 1 to 400 of 400.